DNA

Challenge will improve epilepsy target ID

International pharmaceutical firm Angelini Pharma has launched a new crowdsourcing campaign that aims to capture innovative new ways of target identification in epilepsy, particularly approaches that address the issue of drug-resistant phenotypes.…

Details